ARCHIVES

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

This article is from The Cancer Letter archive.

Vol. 34 No. 18 | May 9, 2008

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009

Commercial Labs Open Drive To Get More NIH Business, Including Grants

April 26, 1974

In Brief: Broder Wins ARC’s Griffuel Prize; Lawyers Trained To Help Low-Income Breast Ca, Patients

October 16, 1992

In Brief: Livingston Completes Term On NCI Board, Appelbaum To Succeed Him as Chairman

November 12, 1999

AAAS Urges Bush To Continue Funding For Stem Cell Research; ONS Hires Arent Fox.

March 9, 2001